As a serious cardiovascular complication, diabetic cardiomyopathy (DCM) refers to diabetes‐
related changes in myocardial structure and function, which is obviously different from those …

Metabolic cardiomyopathy is an emerging cause of heart failure in patients with obesity,
insulin resistance, and diabetes. It is characterized by impaired myocardial metabolic …

Diabetes causes lipid peroxide to accumulate within cardiomyocytes. Furthermore, lipid
peroxide buildup is a risk factor for ferroptosis. This study is aimed at examining whether …

The hallmark feature of Diabetes mellitus (DM) is hyperglycemia which can lead to excess
production of reactive oxygen species (ROS) in the myocardium, contributing to diabetic …

Diabetic cardiomyopathy (DCM) is defined as the presence in diabetic patients of abnormal
cardiac structure and performance (such as left ventricular hypertrophy, fibrosis, and …

Extensive research work has been carried out to define the exact significance and
contribution of regulated necrosis-like cell death program, such as necroptosis to cardiac …

Aims: Krüppel-like Factor 9 (KLF9) is a transcription factor that regulates multiple disease
processes. Studies have focused on the role of KLF9 in the redox system. In this study, we …

Background. DCM is the most common and malignant complication of diabetes. It is
characterized by myocardial dilatation, hypertrophy, fibrosis, ventricular remodeling, and …

Diabetic cardiomyopathy (DbCM) occurs independently of cardiovascular diseases or
hypertension, leading to heart failure and increased risk for death in diabetic patients. To …

Angiotensin-converting enzyme (ACE) inhibitors, which prevent the conversion of
angiotensin I to angiotensin II, are well-known for the treatments of cardiovascular diseases …